Genetic tests exist to identify risk for the rare inherited form of early-onset Alzheimer’s disease (AD) and to predict susceptibility to the more common, late-onset form of AD, but do people want to know, and how do they react? The answers can be found in the article published in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc. The article is available free on the Genetic Testing and Molecular Biomarkers website.
View the original article here: Article addresses tremendous impact of genetic testing for Alzheimer’s – News-Medical.Net